The FDA’s GFI #256 changes have significantly impacted the availability and use of compounded medications in veterinary medicine.
Our educational webinar will help inventory managers and purchasers better understand these changes and their impact on the management of compounded medications.
Submit nominations for the Animal Drug Bulk Substances List.
Though 503A compounded pharmacy products will be limited, FDA Registered 503B Outsourcing Facilities, like Epicur Pharma, are EXCLUDED from this guidance!
This means that you can continue to order and stock all of Epicur’s manufactured medications for your office administration and dispensing needs. View a list of our available drugs now.
